| Telesis Bio Inc. |
Director, 10%+ Owner |
Redeemable Convertible Preferred Stock |
3,385,097 |
$338,509,700 |
$100.00 |
05 Jun 2023 |
Indirect |
| DICE Therapeutics, Inc. |
10%+ Owner |
Common Stock |
633,707 |
$29,467,376 |
$46.50 |
22 Jun 2023 |
By: Northpond Ventures, LP |
| Vigil Neuroscience, Inc. |
10%+ Owner |
Common Stock |
2,831,520 |
$10,618,200 |
$3.75 |
11 Jan 2022 |
By: Northpond Ventures, LP |
| DICE Therapeutics, Inc. |
10%+ Owner |
Common Stock |
166,293 |
$7,732,625 |
$46.50 |
22 Jun 2023 |
By: Northpond Ventures II, LP |
| Vigil Neuroscience, Inc. |
10%+ Owner |
Common Stock |
1,382,978 |
$5,186,168 |
$3.75 |
11 Jan 2022 |
By: Northpond Ventures II, LP |
| Telesis Bio Inc. |
Director, 10%+ Owner |
Long-Term Warrants |
3,385,097 |
|
|
05 Jun 2023 |
Indirect |
| Telesis Bio Inc. |
Director, 10%+ Owner |
Short-Term Warrants |
1,692,549 |
|
|
05 Jun 2023 |
Indirect |
| Vigil Neuroscience, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
11 Jan 2022 |
By: Northpond Ventures, LP |
| Vigil Neuroscience, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
11 Jan 2022 |
By: Northpond Ventures II, LP |